Ingevity Corporation $NGVT Position Cut by Wellington Management Group LLP

Wellington Management Group LLP reduced its holdings in Ingevity Corporation (NYSE:NGVT) by 28.0% during the 2nd quarter, Holdings Channel reports. The fund owned 1,075,514 shares of the company’s stock after selling 418,778 shares during the quarter. Wellington Management Group LLP’s holdings in Ingevity were worth $80,309,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently added to or reduced their stakes in NGVT. AQR Capital Management LLC boosted its position in Ingevity by 10.9% during the 1st quarter. AQR Capital Management LLC now owns 13,410 shares of the company’s stock worth $518,000 after acquiring an additional 1,323 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Ingevity by 5.2% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,790 shares of the company’s stock valued at $863,000 after purchasing an additional 1,080 shares during the period. Empowered Funds LLC raised its stake in shares of Ingevity by 12.9% during the first quarter. Empowered Funds LLC now owns 5,181 shares of the company’s stock valued at $205,000 after purchasing an additional 594 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Ingevity by 311.8% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock worth $23,769,000 after purchasing an additional 454,579 shares during the period. Finally, Jane Street Group LLC lifted its holdings in Ingevity by 306.1% in the first quarter. Jane Street Group LLC now owns 88,883 shares of the company’s stock worth $3,519,000 after purchasing an additional 66,995 shares during the period. Institutional investors own 91.59% of the company’s stock.

Insider Transactions at Ingevity

In other news, SVP Ryan C. Fisher sold 2,709 shares of the firm’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $73.72, for a total transaction of $199,707.48. Following the completion of the transaction, the senior vice president owned 15,722 shares in the company, valued at approximately $1,159,025.84. This trade represents a 14.70% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO David H. Li sold 5,000 shares of the firm’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $75.83, for a total transaction of $379,150.00. Following the transaction, the chief executive officer owned 120,636 shares of the company’s stock, valued at approximately $9,147,827.88. This trade represents a 3.98% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 17,801 shares of company stock worth $1,347,481. 0.88% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts recently issued reports on NGVT shares. Wall Street Zen lowered shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 1st. Weiss Ratings upgraded shares of Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Friday, July 31st. Two research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Ingevity presently has an average rating of “Hold” and an average target price of $80.00.

Ingevity Stock Performance

Shares of NYSE NGVT opened at $69.03 on Thursday. Ingevity Corporation has a 1 year low of $45.85 and a 1 year high of $79.29. The firm has a market cap of $2.37 billion, a P/E ratio of 46.96 and a beta of 1.17. The stock has a fifty day moving average price of $73.27 and a two-hundred day moving average price of $71.67. The company has a debt-to-equity ratio of 22.52, a quick ratio of 1.15 and a current ratio of 1.61.

Ingevity (NYSE:NGVT) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $1.74 EPS for the quarter, topping analysts’ consensus estimates of $1.33 by $0.41. The company had revenue of $314.10 million for the quarter, compared to the consensus estimate of $312.20 million. Ingevity had a return on equity of 284.70% and a net margin of 4.65%.Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. Research analysts forecast that Ingevity Corporation will post 5.4 EPS for the current fiscal year.

About Ingevity

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.